Impax Asset Management Group plc Reduces Holdings in Danaher Corporation $DHR

Impax Asset Management Group plc lowered its stake in shares of Danaher Corporation (NYSE:DHR) by 3.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 506,029 shares of the conglomerate’s stock after selling 15,969 shares during the quarter. Impax Asset Management Group plc owned about 0.07% of Danaher worth $100,325,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Danaher by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after acquiring an additional 788,499 shares during the period. Geode Capital Management LLC boosted its position in shares of Danaher by 0.6% during the second quarter. Geode Capital Management LLC now owns 13,726,194 shares of the conglomerate’s stock valued at $2,697,800,000 after purchasing an additional 81,670 shares in the last quarter. Norges Bank bought a new stake in shares of Danaher during the second quarter valued at approximately $1,979,503,000. Generation Investment Management LLP grew its stake in Danaher by 56.2% in the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock worth $980,914,000 after purchasing an additional 1,787,522 shares during the period. Finally, Franklin Resources Inc. raised its holdings in Danaher by 4.0% in the second quarter. Franklin Resources Inc. now owns 4,822,442 shares of the conglomerate’s stock worth $952,625,000 after purchasing an additional 186,357 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Up 1.4%

Shares of NYSE:DHR opened at $219.66 on Wednesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $242.80. The company has a market cap of $155.16 billion, a P/E ratio of 43.58, a PEG ratio of 2.93 and a beta of 0.91. The stock’s fifty day moving average price is $229.33 and its 200-day moving average price is $215.37.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period last year, the company earned $2.14 EPS. Sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a dividend of $0.32 per share. The ex-dividend date was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is 25.40%.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 3,298 shares of Danaher stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.20% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently commented on DHR shares. Barclays boosted their target price on shares of Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. HSBC boosted their price objective on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, December 1st. Wells Fargo & Company lifted their target price on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Guggenheim boosted their price target on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 2nd. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.